News

Lutonix DCB, CMS, reimbursement, pass-through payment, outpatient use

C.R. Bard Inc. announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has improved the pass-through payment for the Lutonix drug-coated balloon (DCB) under the Medicare hospital...

Medtronic, Euphora SC balloon, CE Mark, Europe, Richard Edwards

Medtronic announced the launch of the Euphora semicompliant balloon dilatation catheter in countries that recognize the CE (Conformité Européene) mark in February. The first patient case with...

Shockwave Medical, Lithoplasty, $40 million, funding, Sofinnova, Venrock

Shockwave Medical announced $40 million in funding, co-led by returning investor Sofinnova Partners and new investor Venrock. Also participating were RA Capital, Deerfield, Sectoral Asset...

IN.PACT Admiral, Global Study, DEB SFA-LONG, long peripheral lesions, EuroPCR

New clinical data from two different studies show the IN.PACT Admiral drug-coated balloon from Medtronic plc successfully treated long lesions in the superficial femoral and popliteal arteries....

Medtronic, Euphora, SC, semicompliant balloon dilatation catheter, FDA, U.S.

Medtronic plc announced U.S. Food and Drug Administration (FDA) 510(k) clearance and U.S. launch of the Euphora Semicompliant Balloon Dilatation Catheter. Euphora is a pre-dilatation therapy used...

Stellarex, Spectranetics, investment, BTK, peripheral artery disease

The Spectranetics Corporation announced it is accelerating investments in the Stellarex drug-coated balloon angioplasty (DCB) platform for treatment of below the knee (BTK) peripheral artery...

Biotronik, Passeo-18 Lux, DCB, BIOLUX P-I, trial, drug eluting, balloon catheter

Biotronik announced that results of its BIOLUX P-I clinical study have been published in the Journal of Endovascular Therapy. BIOLUX P-I was a prospective, international, multi-center,...

Cardinal Health announced plans to acquire Johnson & Johnson’s Cordis business, a leading global manufacturer of cardiology and endovascular devices, for $1.94 billion in cash. 

In.PACT Admiral, PAD, Medicare, pass-through payment, Medtronic, balloon cath

Medtronic announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has approved a transitional pass-through payment for the company’s IN.PACT Admiral drug-coated balloon (DCB)...

Bard, Lutonix, drug coated balloon, DCB, CMS, pass-through payment, outpatient

C. R. Bard Inc. announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has approved a pass-through payment for the Lutonix drug-coated balloon (DCB) under the Medicare hospital...

Lutonix, drug eluting balloon, drug coated balloon

Drug-eluting balloons (DEBs) have been one of the long-awaited new transcatheter technologies to help reduce high restenosis rates in peripheral artery disease (PAD). The U.S. Food and Drug...

Boston Scientific, Bard, Lutonix, DCB, drug coated balloon, distribute

Boston Scientific and C. R. Bard announced a deal where Boston Scientific will distribute the Lutonix 035 drug coated balloon (DCB) percutaneous transluminal angioplasty catheter in the...

Medtronic, In.Pact Admiral DCB, PAD, U.S. launch, drug-coated balloon

United States hospitals began using a new medical device from Medtronic plc  called the In.Pact Admiral drug-coated balloon (DCB) to treat patients with peripheral arterial disease (PAD) in...

drug-eluting balloons, DEB, ECRI, report, peripheral artery disease, PAD, cath

ECRI Institute has created a report that offers an overview of drug-eluting balloon (DEB) technology, “Health Technology Forecast report, "Drug-eluting Angioplasty Balloons for...

Balloon catheters, Heart Valve repair, Cath Lab, Hybrid OR

Maquet Medical Systems USA announced an agreement to serve as the exclusive U.S. distributor of InterValve Inc.'s V8 Aortic Valvuloplasty Balloon Catheter.

Balloon catheters, cath lab, peripheral artery disease (PAD), Lithoplasty

Lithoplasty is a balloon-based technology that utilizes integrated lithotripsy to disrupt both superficial and deep calcium and normalize vessel wall compliance prior to low-pressure balloon...

Covidien announced it has received CE Mark approval for its Stellarex drug-coated angioplasty balloon (DCB). 

Medtronic, In.Pact, Admiral drug-coated balloon, DCB, drug-eluting balloon

The U.S. Food and Drug Administration (FDA) has cleared Medtronic’s In.Pact Admiral drug-coated balloon (DCB) for the interventional treatment of peripheral artery disease (PAD) for the...

balloon catheters, clinical trial/study, medtronic, IN.PACT Admiral drug-coated

The results of a landmark study published this month in Circulation indicate that a device from Medtronic Inc. called the IN.PACT Admiral drug-coated balloon (DCB) significantly...

Cardionovum GmbH announced that it has initiated a 150-patient clinical study of its novel paclitaxel-releasing, high-pressure shunt balloon dilatation catheter, Aperto.